A view of the COVID-19 detection lab in Abu Dhabi.
The lab is capable of conducting tens of thousands RT-PCR tests per day and is the first in the world of this scale to be operational outside of China.
The lab showcases the joint commitment of G42 and BGI to the leadership and people of the UAE, working with the nation to combat the COVID-19 pandemic.
The laboratory, located in Masdar City, Abu Dhabi, was built and operationalised by G42 and BGI in only 14 days, providing an immediate solution to COVID testing scale-up needs in the UAE.
Proactively learning from the China experience in handling the COVID-19 crisis, the lab ensures that the UAE continues to lead the world as the most tested country per capita (according to the WHO).
Peng Xiao, CEO of G42, said, “This high throughput lab provides the scale and firepower to enable all people in Abu Dhabi and the UAE to access the most reliable PCR tests, which are also provided by G42 in partnership with BGI. We thank the UAE leadership’s support in protecting the health and wellbeing of the country’s residents against this pandemic.”
“In such challenging times, we feel compelled to leverage our expertise, technological resources and international partnerships to bring rapid, accurate testing capabilities on a massive scale and bolster the detection efforts led by authorities,” he continued.
This new processing capacity will enable a rapid response to the current outbreak by accelerating the diagnosis, identification of suspected cases, the release of recovered patients, and the screening of close contacts and high-risk groups.
The lab will utilize BGI’s RT-PCR diagnostic kits for the detection of SARS-CoV-2, the virus that causes COVID-19 disease. It is the only RT-PCR diagnostic kit that has received approvals from China (NMPA), Europe (CE-IVD), the United States (FDA) and the World Health Organization (WHO). G42 and BGI, whose partnership began in December 2019 with the announcement of the Population Genome Program by the Department of Health – Abu Dhabi, have stepped up to the forefront in the battle against the COVID-19 pandemic. From the production of COVID-19 diagnostic kits to the supply of thermal sensors and medical goods, the two companies are deploying their expertise and technologies in support of international health authorities as they create effective prevention and detection protocols.
Wang Jian, Co-founder and Chairman of BGI Group, said: “Together with our partners at G42, we can bring the world’s best technology and experience in fighting global health threats to help the people of the UAE and beyond.”
The lab will prioritize testing within the UAE but could scale up to receive samples from neighboring regions. The partners also plan to enable cutting-edge monitoring of virus mutations and the ability to detect new pathogens in the future with high-throughput sequencing.
The two new patients who had recovered were also Chinese citizens, a 41-year old man, and his son, who was eight years of age, the ministry said.
DoH urged the public to rely only on official sources when dealing with all news related to the novel virus.
The Ministry affirmed that it was taking all necessary procedures for investigating, examining and following up with contacts, within the framework of its precautionary measures.
The announcement follows the directives issued by President His Highness Sheikh Khalifa Bin Zayed Al Nahyan, and His Highness Sheikh Mohamed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces.
At least 42,262,290 cases of coronavirus have been registered, of which at least 28,754,900 are now considered recovered. On Friday, 6,366 new deaths and 482,954 new cases were recorded worldwide.
Abu Dhabi Health Services Company, SEHA, hosted John Rakolta Jr., the US Ambassador to the UAE, to share the latest developments surrounding the success of the third phase of the COVID-19 vaccine clinical trials.
The Ministry of Health and Prevention (MoHAP) revealed that that the number of licenced health and pharmaceutical facilities has surged to 3,410, while the total number of workers in the public and private health sector is 26,931.